Eupraxia Pharmaceuticals Releases 'Positive' Additional Data From Study of Eosinophilic Esophagitis Drug Candidate
Eupraxia Pharmaceuticals Releases 'Positive' Additional Data From Study of Eosinophilic Esophagitis Drug Candidate
Eupraxia製藥發佈了有關嗜酸性食道炎藥物候選研究的"積極"額外數據
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間